-
21
Impact of visual presentation of atherosclerotic carotid plaque on cardiovascular risk profile using mHealth technologies
Published 2025-01-01“…Trial Registration: The study was registered at ClinicalTrials.gov under the identifier NCT05096637 on 27 October 2021 and was approved by the local ethics committee of the University of Duisburg-Essen (20-9157-BO).…”
Get full text
Article -
22
-
23
Production of Toxic Volatile Trimethylbismuth by the Intestinal Microbiota of Mice
Published 2011-01-01Get full text
Article -
24
-
25
Intrathecal Resiniferatoxin Modulates TRPV1 in DRG Neurons and Reduces TNF-Induced Pain-Related Behavior
Published 2017-01-01Get full text
Article -
26
HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy
Published 2014-01-01Get full text
Article -
27
-
28
-
29
Consequences of COVID-19 for geriatric patients during a pandemic
Published 2025-01-01“…This study included 468 consecutive geriatric patients (≥ 70 years) who tested positive for SARS-CoV-2 and were treated at the University of Duisburg-Essen from 2/2020 to 3/2021. 74 patients were transferred to a geriatric hospital and a 12-month follow-up (prospective study) was performed in 51 patients. …”
Get full text
Article -
30
-
31
Web-based mindfulness and skills-based distress reduction for patients with cancer: study protocol of the multicentre, randomised, controlled confirmatory intervention trial Reduct
Published 2022-06-01“…The primary endpoint, distress, will be analysed using a baseline-adjusted ANCOVA for distress measurement once the intervention (T1) has been completed, with study arm as a binary factor, baseline as continuous measurement and study centre as an additional categorical covariate.Ethics and dissemination The Ethics Committee of the Medical Faculty Essen has approved the study (21-10076-BO). Results will be published in peer-reviewed journals, conference presentations, the project website, and among self-help organisations.Trial registration number German Clinical Trial Register (DRKS); DRKS-ID: DRKS00025213.…”
Get full text
Article -
32
-
33
Inhibition of tumour necrosis factor alpha by Etanercept attenuates Shiga toxin-induced brain pathology
Published 2025-02-01Get full text
Article -
34
-
35
-
36
-
37
-
38
-
39
-
40